Clinical Trial: Pharmacogenetic Study of Obsessive-Compulsive Disorder

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Pharmacogenetic Study of Obsessive-Compulsive Disorder

Brief Summary: The purpose of this study is to determine whether pharmacogenetic study predict selective serotonin reuptake inhibitor (SSRI) responsiveness in advance before the appearance of the drug effect until 4 months(16 weeks), 6 months, and 1 year after administration of SSRIs.